arrow
M

Marta Marquié

ACE Alzheimer Center Barcelona
H指数:42
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761

单中心开放标签、随机、平行组对照临床试验,研究EGb 761治疗对轻度认知障碍患者炎症和神经退行性变血液标志物的长期效果:ACE-2020-EGb 761

2026-09-290
PRE
A peripheral proteomic signature of Alzheimer’s disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study

阿尔茨海默病的外周蛋白质组学特征在记忆诊所轻度认知障碍患者的血浆外泌体中被鉴定:BIOPEXAL研究

2026-09-100
OA
AMYPAD-PNHS: A Pan-European, Multi-Site & Multimodal MRI Dataset of Older Adults Without Dementia

AMYPAD-PNHS:一项全欧、多中心与多模态MRI数据集,用于无痴呆老年人群

2026-08-030
OAAI
Cortical gray–white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia

皮质灰-白质对比度改变早于非痴呆老年人群中的淀粉样蛋白-β阳性及宏观结构变化

2026-06-230
OAAI
Decreased amyloid-related structure–function coupling in preclinical Alzheimer’s disease

阿尔茨海默病临床前期中淀粉样蛋白相关结构与功能耦合的减弱

2026-06-090
OAAI
Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease

血浆和脑脊液蛋白质数量性状位点的低重叠影响神经疾病的蛋白质发现

2026-04-290
PRE
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease

脑脊液和血浆蛋白质组学揭示脑小血管病新的生物指纹

2025-11-200
OAAI
Amyloid PET predicts atrophy in older adults without dementia: Results from the AMYPAD Prognostic & Natural History study

淀粉样蛋白PET预测无痴呆老年人的萎缩:AMYPAD预后与自然史研究的结果

2025-11-190
OAAI
Federated learning for cognitive impairment detection using speech data

基于语音数据认知障碍检测的联邦学习

2025-10-090
OAAI
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study

基线淀粉样蛋白PET的量化可以在主观认知下降个体中识别淀粉样蛋白积累和认知恶化的风险:FACEHBI研究

2025-04-230
OA
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
2025-03-250
OAAI
Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort

tau PET示踪剂 [18F]PI-2620和 [18F]RO948在患有脑淀粉样蛋白沉积的非痴呆个体中的头对头比较: TAU-PET FACEHBI队列

2024-11-280
OAAI
Metabolic Signature of Insulin Resistance and Risk of Alzheimer's Disease

胰岛素抵抗和阿尔茨海默病风险的代谢特征

2024-11-210
PRE
Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort
2024-11-160
OAAI
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer's disease
2024-11-111
OA
Amyloid deposition in adults with drug-resistant temporal lobe epilepsy
2024-10-150
PRE
Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic

血浆pTau181在记忆诊所大型真实队列中预测阿尔茨海默病病理的临床价值

2024-10-010
OAAI
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
2024-07-231
OA
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

全基因组分析揭示了MAPT,MOBP和APOE基因座在散发性额颞叶痴呆中的潜在作用

2024-07-010
OAAI